Clinical Klebsiellapneumoniae isolates as well as Escherichia coli transformants producing the p-lactamases SHV-2 or SHV-2a demonstrate MIC values for cefotaxime of 4 mg 1-l or 64 to > 128 mg P I , respectively. The plactamases differ by one possibly insignificant amino acid exchange at p i t i o n number 10 of the mature protein; their kinetic parameters are rather similar. The 5' untranslated regions of both corresponding genes show no homology starting 74 nucleotides upstream to the start codon. Hybridization of intragenically annealing oligonucleotides to dot-blotted serial dilutions of total cellular RNA from E. coli transformants harbouring these genes cloned into the same vector plasmid gave a positive signal down to 1.2 pg (SHV-2) and 0.32 to 0.16 pg (SHV2a), indicating a four to eight times higher amount of specific transcript in the case of SHV-2a. By primer extension analysis and S1 nuclease digestion the starting point of transcription was located 100 nucleotides (SHV-2) and 50 nucleotides (SHV-2a) in front of the start codon. No other transcripts of different length could be detected after prolonged exposure. Northern blot analysis demonstrated the length of the p-lactamase mRNA to be about 1.6 kb in both cases, thus comprising a potential open reading frame downstream of the two enzymes' genes. Selective PCR amplification of both promoter regions and of the structural gene of SHV-2 and subsequent combined cloning of each of the promoters and the SHV-2 gene into pBGSl9 using a B m H I restriction site introduced by three point mutations into the cloned sequences was employed to transform E. coli DH5a. The MIC value for cefotaxime of transformants harbouring the SHV-2 promoter and SHV-2 structural gene was 8 mg 1-l , but was 64 mg 1-l in the case of the SHV-2a promoter and SHV-2 structural gene combination, indicating that the quantitative change of resistance to cefotaxime of SHV-2a-producing bacteria is caused solely by a significant promoter mutation.
Introduction
In the last few years an increasing number of plasmidcoded /I-lactamases from members of the Enterobacteriaceae such as Escherichia coli and Klebsiella spp. have been described. Initially the investigators' attention was drawn to these bacteria because of the increased resistance of a given isolate to a newer /I-lactam, e.g. a methoxyiminocephalosporin. Analysis of the mechanism of resistance most often yielded an altered /Ilactamase, mainly from the groups of TEM or SHV enzymes. At present, at least 19 TEM-group and eight SHV-group P-lactamases (references summarized in : Mabilat & Courvalin, 1990; Podbielski et al., 1991) have been characterized, many of them at the nucleotide sequence level. In all cases the genes of these enzymes Abbreviation : PCR, polymerase chain reaction.
0001-6705 0 1991 SGM differed in a few point mutations, leading to even fewer amino acid exchanges, with one or two of these in the pouch of the active site of the enzyme, thus in some cases affecting the enzyme's affinity for a given /?-lactam compound and by this means the rate and effectivity of its hydrolysis (Labia et al., 1988; Collatz et al., 1989) . Besides the possibility of reaching an increased level of resistance to recently developed P-lactams by introducing appropriate point mutations within the structural gene of the P-lactamase, there exists another mechanism of adaptation for the bacteria, namely by augmenting the rate of expression of the enzyme, a point that only a few investigators have considered. Obvious differences between /I-lactamase promoters of Gram-negative bacteria are well characterized only in the case of transposonand plasmid-encoded TEM enzymes (Chen & Clowes, 1984 , 1987 Sougakoff et al., 1988; ).
Recently, we described a variant of the SHV-2 /I-A. Podbielski and others lactamase, SHV-2a, whose kinetic parameters with respect to different methoxyiminocephalosporins did not differ significantly from the original SHV-2 enzyme ; but when SHV-2a was expressed by the natural Klebsiella pneumoniae host, the bacteria showed an increased minimum inhibitory concentration (MIC) for cefotaxime of at least 128 mgl-1 (Podbielski et al., 1991) . Comparison of the genes and neighbouring nucleotide sequences revealed three point mutations within the gene leading to one amino acid exchange of questionable importance. Gene dosage effects could be excluded, since SHV-2 and SHV-2a appear as single-copy genes in their original hosts, as judged by hybridization experiments using intragenic probes and restriction-enzymedigested genomic and plasmid host cell DNA. In contrast, the 5' untranslated regions of both genes were totally different starting 74 nucleotides upstream of the start codon, which is within the putative promoter region. Since only one research group (Arakawa et al., 1986) had tried to establish the SHV promoter sequence for the chromosomally encoded SHV-type P-lactamase LEN-1 (presumably by homology identification), we decided to characterize the SHV-2 and SHV-2a promoters experimentally and subsequently to analyse the actual strength of each promoter in order to explain the different MICs for cefotaxime of Kfebsiella isolates producing these enzymes.
Methods
Bacterial strains, plasmids and media. E. coli DH5a (BRL) was used as a host strain for recombinant plasmids. High-copy-number plasmid pBGS19 (Spratt et al., 1986) served as a vector plasmid. Recombinant plasmids pBP60-1-2 and pZMP1-1-1, harbouring a 2.3 kb insert including the gene for SHV-2 and a 2.2 kb insert including the SHV-2a gene, respectively, each cloned into pBGSl8, have been described elsewhere (Kliebe et al., 1985; Podbielski et al., 1991) .
DST agar (Unipath Oxoid) was used for routine culturing of bacteria. When required, it was supplemented with ampicillin (50 mg 1-I) or cefotaxime (2 mg 1-I). Recombinant clones were screened on H agar (protocol by Boehringer Mannheim) supplemented with kanamycin (30 mg l-l), X-Gal and ITPG.
MICs were assessed by the Microscan system (Baxter) in ready-to use microtitre plates, following the protocol of the manufacturer.
Preparation of nucleic acids. Small-scale preparation of plasmid DNA was done by the method outlined by Zhou et al. (1990) . In the case of DNA sequencing this method was scaled up, followed by phenol extraction and ethidium bromide/CsCl density gradient centrifugation in a Beckman TLV 100K rotor at 100OOOr.p.m. for 3 h. Bands containing covalently closed circular plasmid DNA were punctured and drawn off with a hypodermic syringe and ethidium bromide was extracted from these by phenol treatment. Two micrograms of this DNA suspended in TE buffer (10 mM-Tris pH 7.5, 1 mM-EDTA) was used for an individual sequencing reaction. When appropriate, single DNA fragments generated by polymerase chain reaction (PCR) amplification or restriction digests were electroeluted from agarose gels and purified by affinity chromatography on NACS-52 (BRL) according to the manufacturer's instructions. Total cellular RNA was isolated according to the protocol of Reddy et al. (1990) . Concentration of RNA solutions was measured spectrophotometrically at 260 nm. D N A techniques. Restriction enzyme digests, DNA ligation, 1 % (w/v) agarose gel electrophoresis and Southern blotting by vacuum onto Biodyne B nylon membranes (Pall Bio Support) were done by conventional methods (Sambrook et al., 1989) . The enzymes necessary for these procedures were purchased from Boehringer Mannheim. Transformation of E. coli recipients was performed as outlined by Hanahan (1983) ; colony blots were done according to Maas (1983) . Hybridization with non-radioactively labelled oligonucleotide probes and visualization with the Photogene system (BRL) was described earlier (Podbielski et al., 1990) ; stringent hybridization temperatures were selected 5 to 10 "C below the calculated melting temperature (7'& using the OLIGO program (National Bioscience Inc.) for calculation. Oligonucleotides for probing, sequencing and primer extension experiments ( Fig. 1 ) were synthesized on a Beckman 200A DNA synthesizer, eluted, deprotected and desalted following the instructions of the manufacturer. Oligonucleotides for RNA dot-blot and Northern blot hybridization were 5' labelled using [Y-~~P]ATP (Amersham) according to Sambrook et al. (1989) .
DNA sequencing was performed by the dideoxy chain-termination method (Sanger er al., 1977) using the T7 sequencing kit (Pharmacia), pUC standard forward and reverse primers and [a-3SS]dATP (Amersham) as exemplified in the instructions of the manufacturers. Sequences were analysed with the aid of the PC GENE program (IntelliGenetics) on a IBM PS-2 personal computer.
PCR was run in a Techne PHC 1 thermal cycler. The reaction volume of 100 pl contained (final concentrations): 1 pg template DNA, 200 pM-dNTPs, 1 phi of each primer, 50 mM KCl, 10 mM-Tris pH 8.3, 1-5 mM-MgC12 and 0.01 % (w/v) gelatin; it was overlaid with 100 pl mineral oil, heated to 100 "C for 5 min, 2 U of Tuq polymerase (BRL) was added and the assay was placed into the cycler where the cycling programme was immediately started. The programme consisted of 27 cycles at 94°C for 1 min, 55 "C for 1 min and 72°C for 2.5 min, followed by a final segment of 72 "C for 7-7 min. The mineral oil overlay was extracted with 100 p1 chloroform, and, if appropriate, the amplification products were analysed or prepared for further experiments by electrophoresis on a 1% agarose minigel using Trislphosphate/EDTA as running buffer.
RNA techniques.
Northern and dot-blotting of total cellular RNA onto Biodyne B nylon membrane was done as outlined by Davis et al. (1986) . Hybridization of dot-blotted and Northern-blotted RNA with 5' radioactively labelled oligonucleotides was performed under the same conditions as hybridization with non-radioactively labelled probes (see above).
For primer extension analysis as modified from Inoue & Cech (1989, 1 pmol oligonucleotide primer was dissolved in 5 pl hybridization buffer I (60 mM-NaCl/SO mwTris pH 8.3/10 mM-DTT), and 20 pg total cellular RNA dissolved in 5 pl hybridization buffer I was added. The mixture was heated to 90 "C, gradually cooled to 30 "C over a period of 45 min, then 1 pl 60 rn~-MgCl, was added. Five microlitres of this mixture were transferred to a new tube containing 3 pl dCTP/dGTP/dTTP dissolved in hybridization buffer I/6 m~-MgCl, at a final concentration of 200 p~ of each nucleotide, 1-5 p1 [a-j5S]dATP and 2 p1 (400 U) MMTV reverse transcriptase (BRL). The assay was incubated at 37 "C for 5 min, then 1 p12 mM-dATP was added and the incubation continued for a further 30 min at 37 "C. After this the reaction was stopped by adding 5p1 loading buffer (90%, v/v, formamide/20 mM-EDTA/bromophenol blue and xylene cyanol 1 mg ml-' each). Before loading onto a 8% (w/v) polyacrylamide sequencing gel with dideoxy termination sequencing reaction mixtures in parallel as nucleotide length markers, the primer extension reaction mixture was denatured by the conventional procedure (5 min at 95 "C, 5 min on ice, spin in a centrifuge, 2 min at 95 "C, 2 min on ice, spin again) .
For S1 nuclease digestion mapping as modified from Aiba et al. The DNA-RNA hybridization assay was heated to 85 "C for 10 min, and then kept at the hybridization temperature overnight. The hybridization temperature to be used depends on the GC content of the annealing region (SHV-2a, 51.2%; SHV-2, 46.7%) and was deduced from Sambrook et al. (1989) . Thus, 59 "C and 52 "C for SHV-2, and 64 "C and 55 "C for SHV-2a were chosen. At the end of hybridization, 300 pl ice-cold S1 nuclease mapping buffer (0-3 ~-NaC1/50 mM-sodium acetate/5 m~-ZnS0,/20 pg ml-l fresh denatured caIf thymus DNA/750 U S1 nuclease per ml final volume) was directly added, mixed quickly and transferred to 37 "C for 2 h. The reaction was stopped by immediate cooling on ice and addition of 80 pl stop mixture (4 M-ammonium acetate/50 ~M -E D T A /~O pg ml-l yeast tRNA), extracted once with phenol/chloroform and precipitated with ethanol. The pellet was dissolved in 4p1 TE buffer, 6pl loading buffer was added and after conventional denaturation loaded onto a sequencing gel in the same way as for the primer extension analysis.
Northern blot hybridization
For hybridization to Northern blots loaded with identical amounts of total cellular RNA of E. coli DH5a transformed with the SHV-2 and SHV-2a genes cloned into pBGS18 (pBP60-1-2 and pZMP1-1-1, respectively) a mixture of three intragenically annealing oligonucleotides ( Fig. la) was selected as a probe. Comparing the major signal on the blot of the 1 DNA/HindIII size standard, the length of the specific transcript was estimated as approximately 1-6 kb. Densitometric evaluation of the hybridization bands indicated an approximately four to five times stronger signal from the SHV-2a RNA.
RNA dot-dot hybridization Total cellular RNA from E. coli transformants harbouring the recombinant plasmids pBP60-1-2 (SHV-2) and pZMP 1-1 -1 (SHV-2a) was serially diluted in twofold steps and dot-blotted onto the nylon membrane. The highest amount of blotted RNA was 40 pg in both cases. The mixture of intragenically annealing oligonucleotides (Fig. 1 a) was again used as detection probe. The results are shown in Fig. 2 . A signal clearly above background could be detected with 1.25 pg blotted total cellular RNA in the case of SHV-2, compared to 0.32 to 0.16 pg in the case of SHV-2a. Thus, in the preparation of total cellular RNA containing the SHV-2a mRNA there was about four to eight times more of the specific transcript compared to that of SHV-2.
Promoter mapping of the SHV-2 and SHV-2a genes Promoter mapping was achieved by the use of two different methods, primer extension analysis and S 1 nuclease digestion. The three different primers used for the primer extension analysis are shown in Fig. l(b) .
As a control for irregularities in the sequencing gels, each individual assay as well as each sequencing reaction as a size standard was loaded onto the gel twice in one run, at different times.
Reverse transcription of the mRNA templates led to identical results irrespective of the primer chosen. S1 nuclease digestion was only effective in the case of the lower hybridization temperatures. The transcription start points defined by primer extension analysis and by S1 nuclease mapping were in excellent agreement.
As examples, representative regions of the sequencing gels loaded with reaction mixtures from primer extension and S1 nuclease assays are shown in Figs 3 and 4, respectively. The transcription start point (position + 1) for the SHV-2 gene was mapped 100 nucleotides in front of the translation start codon ATG; that of SHV-2a was mapped 50 nucleotides in front of ATG. The alignment of the SHV-2 and SHV-2a sequences upstream of the start codons and the deduced sequences of the corresponding -35 and -10 boxes are shown in Fig. 5 .
Selected PCR-mediated amplijication and cloning of the SH V-2 and SH V-2a promoters and SH V-2 structural gene ; determination of MICs of resulting recombinant clones Two DNA fragments of 510 nucleotides, including the SHV-2 and SHV-2a gene promoters, respectively, were successfully amplified by PCR using the primers shown in Fig. 1 (c) and both were cloned separately into pBGS19 via restriction sites for EcoRI (5' end) and BamHI (3' end) added to the 5' ends of the PCR primers. The BamHI site lies between the Shine-Dalgarno sequence and the start codon of the gene and is created by introducing three point mutations in this stretch of sequence. Positive recombinant clones were initially spotted by white/blue selection and subsequently after colony blotting by hybridization with oligonucleotide no. I in Fig. l(b) . Effective cloning was confirmed and unwanted mutations introduced by the PCR reaction were excluded by sequencing these recombinant clones Characterization of SHV p-lactamase promoters 167 1 Fig. 2 . Hybridization of intragenically annealing oligonucleotides to dot-blotted serial dilutions of SHV-2 and SHV-2a mRNA. The amounts (pg) of dot-blotted total cellular RNA are shown above the photograph. For hybridization a mixture of radioactively labelled oligonucleotides (Fig. 1 a) was used.
on one strand prior to further recombination experiments. Cloning of the SHV-2 structural gene followed the procedures outlined above, using artificial BamHI (5' end) and HindIII (3' end) restriction sites for cloning, and the mixture of oligonucleotides of Fig. 1 (a) for screening in colony blot hybridization thereafter. The recombinant plasmids containing the SHV-2 or SHV-2a promoters or the SHV-2 structural gene were designated pZMP2-P, pZMP2a-P and pZMP2-S, respectively. The SHV-2 gene was cut out of pZMP2-S by BamHI and HindIII digestion and after separation and cleaning of the fragment was cloned into the corresponding sites of pZMP2-P and pZMP2a-P. E. coli transformants harbouring the new recombinant plasmid were selected on DST agar supplemented with ampicillin or cefotaxime. Plasmid DNA of cefotaxime-resistant clones was analysed by triple digestion with BamHI, EcoRI and HindIII and confirmed to contain the desired compound genes by DNA sequencing.
Five clones each harbouring the recombinant plasmids designated pZMP2-P/2-S (SHV-2 promoter and structural gene) and pZMP2a-P/2-S (SHV-2a promoter and SHV-2 structural gene) were subjected to MIC determination for a panel of P-lactams. The mean values are presented in Table 1 . Recipient E. coli DH5a devoid of any plasmid was tested in parallel and proved to exhibit MIC values as already published (Podbielski et al., 1991 ; data not shown).
Discussion
The first description of a promoter of a chromosomally encoded SHV type P-lactamase, LEN-1, was by Arakawa et al. (1986) . However, these authors did not Fig. 3 . Example of a primer extension analysis for the assessment of the transcription start point of SHV-2a mRNA. Lane 1, sequencing assay as size reference; lanes 3, 5 and 7, extension of primers I, I11 and I1 (Fig. 1 b) , respectively, using SHV-2a mRNA as a template; lanes 2, 4,6 and 8, each reaction mixture loaded onto the gel for a second time 1.5 h after starting the first run. elaborate in detail how they came to the conclusion that the described nucleotide sequences belong to the promoter. All other groups who later published new nucleotide sequences of plasmid-coded SHV #?-lactamases cited the study of Arakawa et al. (1986) when mentioning a putative promoter site. Since almost all nucleotide sequences adjacent to the 5' end of a given SHV gene are highly homologous, -differences in MIC values for newer P-lactams have largely been ascribed to amino acid exchanges found in the structural gene. Only the 5' untranslated region of SHV-2a and another very similar SHV-2 variant enzyme (Garbarg-Chenon et al., 1990) differ from the rest of the sequences in so far showing homology of less than 50% starting 74 nucleotides 5' to the start codon in the upstream direction. Because the much higher MIC values for cefotaxime of the original Klebsiellu pneumoniae producers of SHV-2a compared to those harbouring SHV-2 did not correspond with the similar kinetic values of the SHV-2 and SHV-2a enzymes, we decided to analyse the promoters involved.
In this paper we present the different promoters of the P-lactamases SHV-2 and SHV-2a, both assessed for the first time by experimental means. We determined the starting point of transcription by two different assays to circumvent the specific problems inherent in each method, which might lead to wrong or ambiguous results when using only one of them. In addition we used three different primers for the primer extension analysis since the reverse transcriptase tends to leave the template stand prematurely when it encounters secondary structures often found in single-stranded RNA. The results by every assay of both methods. are in .excellent agreement.
The starting points of the specific transcripts for the two #?-lactamases differ by 50 nucleotides, being 100 nucleotides in front of the start codon ATG in the case of SHV-2 and 50 nucleotides in the case of SHV-2a.
Having a guanosine as the first nucleotide of the SHV-2 transcript is in accordance with the majority of transcripts presenting a purine nucleotide at this position (Horwitz & Loeb, 1990) ; in contrast, the transcript of SHV-2a starts with a cytidine. Knowing these starting points we deduced the -10 and -35 boxes of the corresponding promoters by simply counting the nucleotides in the 5' direction and applying rules like the special conservation of the TTG motif in the -35 box, which is said to lead to heteronomous DNA configuration and therefore to facilitate strand selection for the RNA polymerase (Horwitz & Loeb, 1990) , and the conservation of spacer length between the -35 and -10 box necessary for a coordinate contact of the RNA polymerase to the template strand prior to the beginning of transcription (Beutel & Record, 1990) . Comparison of the nucleotide sequences of the deduced -10 and -35 boxes of the SHV promoters with the consensus sequences given by Hawley & McClure (1983) shows that the promoter of SHV-2, and especially its -10 box, deviates more from the consensus sequence than that of SHV-2a (Fig. 5) . This could be a reason for the lower strength of the SHV-2 promoter, since promoters which lack homology with the consensus sequence are generally less efficient at initiating transcription than promoters Table 1 . Mean MIC values for selected Ij-lactams o j j v e E. coli transformants each harbouring pZMP2-PI2-S and p ZMP2a-P/2-S pZMP2-P/2-S and pZMP2a-P/2-S are the recombinant plasmids containing the SHV-2 structural gene and the SHV-2 or SHV2a promoter, respectively. For comparison, the corresponding MIC values of E. coli transformants harbouring pZMP 1-1 -1 (SHV-2a; Podbielski et al., 1991) and pBP60-1-2 (SHV-2; Kliebe et al., 1985) are shown. ND, Not determined.
MIC value (mg 1-l) with a high degree of homology (Rosenberg & Court, 1979; Hawley & McClure, 1983; Kobayashi et al., 1990) . The lower homology of the SHV-2 promoter to the consensus sequence and the simultaneous presence of potential promoter sequences at the position corresponding to the SHV-2a promoter exhibiting a higher degree of homology explains why a computer search for potential promoter sites on the SHV-2 DNA may fail. Even if present, this site is not used for the start of transcription of SHV-2 mRNA, because there is no evidence for a second transcript of different length, in the case of either SHV-2 mRNA or SHV-2a mRNA, as judged from the results of primer extension and Sl nuclease digestion assays and the Northern blots even after prolonged exposure. The inactivity of the site given by Arakawa et af. (1986) as a promoter may be caused by the aberrant length of the spacer region between the potential -35
and -10 boxes: it is one nucleotide longer than the consensus length of 18 nucleotides. Both promoters and the intervening regions downstream of the start codons show no significant similarity to those of the TEM /?-lactamases (Russell & Bennett, 198 l) , to inducible promoters of chromosomally encoded /?-lactamases (Lindberg & Normark, 1986; Forsman et af., 1989) or to regulatory sequences sensitive to heatIabile protein, which may couple the /?-lactamase expression to the SOS response (Kuriki, 1989) .
Starting 178 bp downstream of the stop codon of the SHV genes, there is a 318 bp open reading frame of unknown function perfectly conserved in all SHV nucleotide sequences published so far. Considering the starting points of transcription and the length of the specific transcripts, SHV mRNAs may be polycistronic, because they include this open reading frame.
The PCR-mediated cloning of the different SHV promoters and of the structural gene of SHV-2 and the subsequent recombinant cloning of both promoters in front of the p-lactamase gene could only be achieved by creating a restriction site, here between the ShineDalgarno sequence and the start codon, via the introduction of three point mutations. The resulting potential hairpin structure may influence the efficiency of transcription or translation by an attenuation process (Lindberg & Normark, 1986; Lovett, 1990; de Smit & van Duin, 1990 ). But we think we can exclude any influences of the manipulations we made with these sensitive parts of the genes, because: (a) the clones containing the SHV-2 promoter/SHV-2 structural gene combination exhibit nearly the same MIC values for plactams as those harbouring the complete natural gene cloned into the same vector plasmid; and (6) the numerical difference of the amount of specific mRNA produced by bacteria transformed with recombinant plasmids containing the complete SHV-2 and SHV-2a genes, respectively, is in the same range as the difference of the MIC values, especially for cefotaxime, of E. coli transformants harbouring the PCR-derived substructures of the genes.
On the other hand we cannot exclude the influence of upstream regulatory sequences like those described by Urabe et al. (1990) because the amplified promotercontaining DNA fragments are long enough to comprise such regions and the sequences 500 to 300 bp upstream of the start codon are diverse, so they may exert different influences on the downstream promoters. This influence would have to be caused by cis-acting elements, because we did not amplify the open reading frame situated upstream of the SHV-2a P-lactamase gene (1 135 to 899 nucleotides in front of the start codon; there is none in front of the SHV-2 gene). The method of selective PCR amplification of potential regions of interest on the DNA and their successive combined cloning to functional structures that we employed in this study may serve to answer such questions in future.
In conclusion, we have demonstrated by in vitro and in vivo experiments an alternative means of quantitative adaptation of a plasmid-borne p-lactamase to confer upon its Klebsiella host a higher level of resistance to a third-generation cephalosporin. The different promoter of SHV-2a alone is sufficient to generate the increased level of resistance to cefotaxime found in bacteria producing SHV-2a. This was confirmed by testing the in vivo effect of the different promoters in front of the same structural gene in otherwise identical host bacteria. This study documents that when looking for the reason for increased in vivo activity of a bacterial isolate against a given substrate, in some cases it may be insufficient to concentrate solely on small mutations of the structural gene of the enzyme, thereby overlooking changes in the regulatory domains.
